Keyoung Hansoo Michael
SEC CIK 1824764 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KAPA | Kairos Pharma, LTD. | Dir | 29.1K | — | — | 1 | 2025-09-16 | 2025-09-16 |
Most active insiders at KAPA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Samuelson Doug | CFO | — | — |
| 2 | Bhowmick Neil | CSO | — | — |
| 3 | Murali Ramachandran | VP of Research, Development | — | — |
| 4 | Yu John S | CEO, COB, Dir, 10% | — | — |
| 5 | Singhvi Rahul | Dir | — | — |
Keyoung Hansoo Michael made no open-market trades at KAPA in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-26 | 2025-09-16+ | KAPA | Kairos Pharma, LTD. | Keyoung Hansoo Michael | Dir | A - Grant | $0.00 | +29.1K | 29.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations